Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Epsilogen Ltd logo — Harnessing the power of IgE

Epsilogen Ltd

Harnessing the power of IgE

Founded 2016 United Kingdom United Kingdom 33 employees Series B Total: $39.95M Biopharma, Biotechnology +2

General Information

Company Name Epsilogen Ltd
Founded Year 2016
Location United Kingdom United Kingdom +1
Founders / Decision Makers
Team member
Employees 33
Industries Biopharma, Biotechnology, Health and Wellness +1
Funding Stage Series B
Social

Get notified when Epsilogen Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Epsilogen Ltd

Epsilogen is a biopharmaceutical startup based in the United Kingdom, founded in 2016. The company is focused on harnessing the power of IgE antibodies for cancer treatment, aiming to address solid tumors with greater potency, enhanced access, and a long tissue half-life. Epsilogen's lead program targets the folate receptor alpha (FR alpha) and has initiated a phase I trial for the treatment of ovarian cancer. Notably, Epsilogen achieved a significant milestone with a £30.75M Series B investment on 02 March 2022. The investment was led by a syndicate of investors including Novartis Venture Fund, 3B Future Health Fund, ALSA Ventures, British Patient Capital, Caribou Property, Epidarex Capital, and Schroders Capital. With its innovative approach to IgE therapeutics and substantial financial backing, Epsilogen has positioned itself as a promising player in the field of cancer treatment.

Taxonomy: cancer treatment, immunoglobulin antibodies, IgE therapy, solid tumors, oncology, phase I trial, folate receptor alpha, anti-cancer drugs, clinical development, global leader, immunotherapy, tumor targeting, immune response, clinical trials, biopharmaceutical

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 7
Investor Investor Investor Investor Investor Investor Investor
02 Mar 2022
Grant •••••• 1
Investor
02 Apr 2019
Series A •••••• 2
Investor Investor
30 Nov 2018
Grant •••••• - 09 May 2018
Series A •••••• - 20 Jun 2017

Epsilogen Ltd Alternatives & Competitors

Epsilogen Ltd vs
Alpha Cancer Technologies Inc.
Alpha Cancer Technologies Inc. Canada

HARNESSING NATURE TO BEAT CANCER

5 employees
Biotechnology, Pharmaceutical
Compare Epsilogen Ltd vs Alpha Cancer Technologies Inc.
Epsilogen Ltd vs
Oncoinvent ASA
Oncoinvent ASA Norway

Innovations for better cancer care

Series Unknown
47 employees
Biotechnology, Life Sciences
Compare Epsilogen Ltd vs Oncoinvent ASA
Epsilogen Ltd vs
Alpha Tau Medical
Alpha Tau Medical Israel

Revolutionary Alpha Emitters Radiotherapy

Post Ipo Equity
98 employees
Health Care, Medical Devices
Compare Epsilogen Ltd vs Alpha Tau Medical

FAQ About Epsilogen Ltd

Harnessing the power of IgE
Epsilogen Ltd was founded in 2016.
Epsilogen Ltd is headquartered in United Kingdom.
Epsilogen Ltd operates in the following industries: Biopharma, Biotechnology, Health and Wellness, Life Sciences.
Epsilogen Ltd has approximately 33 employees.
Epsilogen Ltd has completed 5 funding rounds, raising a total of $39.95M. The latest funding stage is Series B.
Top alternatives and competitors to Epsilogen Ltd include Alpha Cancer Technologies Inc., Oncoinvent ASA, Alpha Tau Medical, Genelux, Aurora Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Epsilogen Ltd and Alpha Cancer Technologies Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Epsilogen Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy